Odontogenic ameloblast-associated protein as a tumor biomarker

Details Odontogenic ameloblast-associated protein as a tumor biomarker Odontogenic ameloblast-associated protein as a tumor biomarker

G - Physics

01

N

G01N 33/574 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2718716

Odontogenic ameloblast-associated (ODAM) protein may be used as an effective biomarker in humans for various cancers, especially those of epithelial origin, such as breast, lung, and stomach. The ODAM protein may be detected in cancerous cells. Additionally, the blood of patients with such cancers contains high titers of anti-ODAM antibodies.

Linvention concerne une protéine associée à laméloblaste odontogène (ODAM) qui peut être utilisée comme biomarqueur efficace chez des êtres humains pour divers cancers, particulièrement ceux dorigine épithéliale, telle que le sein, le poumon et lestomac. La protéine ODAM peut être détectée dans des cellules cancéreuses. De plus, le sang de patients avec de tels cancers contient des titres élevés danticorps anti-ODAM.

Affiliated with

Also associated with

Rating

Odontogenic ameloblast-associated protein as a tumor biomarker does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Odontogenic ameloblast-associated protein as a tumor biomarker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Odontogenic ameloblast-associated protein as a tumor biomarker will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1964290